搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
3 小时
on MSN
Merck snaps six straight sessions of losses
Shares of Merck (NYSE:MRK) traded marginally higher on Friday after falling from a high of $119.38 from the past seven ...
2 天
on MSN
Merck says trial of combination treatment for colon cancer failed to meet main goal
Merck & Co.’s said a late-stage trial of its blockbuster cancer drug Keytruda in combination with favezelimab failed to meet ...
2 天
on MSN
Merck's colorectal cancer therapy fails late-stage trial
Merck said on Wednesday its therapy did not meet the main goal of a late-stage trial evaluating it in patients with a type of ...
12 小时
on MSN
Merck & Co., Inc. (MRK): An Undervalued Wide Moat Stock to Buy According to Analysts
We recently compiled a list of the 10 Undervalued Wide Moat Stocks to Buy According to Analysts. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the ...
1 天
Merck & Co. Inc. stock underperforms Thursday when compared to competitors
Shares of Merck & Co. Inc. MRK slipped 1.43% to $113.09 Thursday, on what proved to be an all-around favorable trading ...
2 天
Merck fails in late-stage trial for Keytruda combo in colon cancer
Merck (MRK) stock is in focus as a Phase 3 trial for its cancer drug Keytruda in colorectal cancer patients did not meet ...
13 小时
Evaxion Biotech Gains Buy Rating Amid Merck Collaboration and AI-Driven Vaccine Development ...
Swayampakula Ramakanth, an analyst from H.C. Wainwright, maintained the Buy rating on Evaxion Biotech (EVAX – Research Report). The ...
新浪网
3 天
医药一哥放了一颗卫星,但是仍有遗憾
炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 2024年9月19日,“医药一哥”恒瑞医药宣布,其自主研发的创新药瑞拉芙普-α注射液(SHR-1701)的药品上市许可(金麒麟分析师)申请,已经获国家药监局受理,适应症为:本品联合 ...
18 小时
Merck KGaA's (ETR:MRK) earnings growth rate lags the 11% CAGR delivered to shareholders
When we invest, we're generally looking for stocks that outperform the market average. Buying under-rated businesses ...
中時新聞網
15 小时
《兴柜股》圣安生医靶向性外泌体药物递送平台 夺默克药厂特别奖
圣安生医(6926)以创新HLA-G标靶外泌体药物递送平台(SOB100)系列药物的研发,荣获第11届默克(Merck)特别奖。默克全球新兴生物科技资助项目于2014年启动,虽然每年提供全球不同区域的生技公司申请,这是继2019年第一次 ...
1 天
保市场保价格两难抉择:上半年地塞米松销量减少2600万元,仙琚制药 ...
这一价格异常波动引起了官方的关注。2023年11月6日,地塞米松磷酸钠注射液被纳入第九批国家药品集采,中选价格骤降至0.23元/支,降幅高达98%。受此影响,2024年一季度,地塞米松磷酸钠注射剂在国内院内市场的销售额同比下滑了47.8%。即便未中选 ...
2 天
Merck Says Phase 3 KEYFORM-007 Study Did Not Meet Primary Goal Of Overall Survival
Merck & Co Inc. (MRK) on Wednesday said its Phase 3 KEYFORM-007 study evaluating the company's drug candidate favezelimab in ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈